BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24711272)

  • 1. Time-resolved cellular effects induced by TcdA from Clostridium difficile.
    Jochim N; Gerhard R; Just I; Pich A
    Rapid Commun Mass Spectrom; 2014 May; 28(10):1089-100. PubMed ID: 24711272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clostridial glucosylating toxins on the proteome of colonic cells determined by isotope-coded protein labeling and LC-MALDI.
    Jochim N; Gerhard R; Just I; Pich A
    Proteome Sci; 2011 Aug; 9():48. PubMed ID: 21849038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Clostridium difficile Toxin A on the proteome of colonocytes studied by differential 2D electrophoresis.
    Zeiser JJ; Klodmann J; Braun HP; Gerhard R; Just I; Pich A
    J Proteomics; 2011 Dec; 75(2):469-79. PubMed ID: 21890007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
    Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
    BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Schweitzer T; Genth H; Pich A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077344
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxin A of the nosocomial pathogen Clostridium difficile induces primary effects in the proteome of HEp-2 cells.
    Junemann J; Birgin G; Erdmann J; Schröder A; Just I; Gerhard R; Pich A
    Proteomics Clin Appl; 2017 Mar; 11(3-4):. PubMed ID: 27860399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from
    Sapa D; Brosse A; Coullon H; Péan de Ponfilly G; Candela T; Le Monnier A
    Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38251254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 15. Difference in Mono-O-Glucosylation of Ras Subtype GTPases Between Toxin A and Toxin B From
    Genth H; Junemann J; Lämmerhirt CM; Lücke AC; Schelle I; Just I; Gerhard R; Pich A
    Front Microbiol; 2018; 9():3078. PubMed ID: 30622517
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucosyltransferase-dependent and -independent effects of TcdB on the proteome of HEp-2 cells.
    Erdmann J; Junemann J; Schröder A; Just I; Gerhard R; Pich A
    Proteomics; 2017 Aug; 17(15-16):. PubMed ID: 28612519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
    Frädrich C; Beer LA; Gerhard R
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
    Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory-based evaluation of TOX A/B QUIK CHEK "NISSUI" to detect toxins A and B of clostridium difficile].
    Nakasone I; Shiohira CM; Yamane N
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2007; 18(2):109-16. PubMed ID: 18154439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.